http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008166695-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
filingDate | 2008-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317ba6a9f15ef2354d73f64e61ba07ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb4835ff9037d19a03717e1c17c67962 |
publicationDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2008166695-A1 |
titleOfInvention | Solution for the storage and perfusion of organs awaiting transplantation |
abstract | A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1 -100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012088269-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005920-B2 |
priorityDate | 2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 509.